Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-024-03296-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Wei-Syun Hu und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, China Medical University, Taichung, 40402, Taiwan. weisyunhu@gmail.com. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Hypoglycemic Agents, Sodium-Glucose Transporter 2 Inhibitors, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, College of Medicine, China Medical University, Taichung, 40402, Taiwan. weisyunhu@gmail.com.
- Division of Cardiovascular Medicine, Department of Medicine, China Medical University Hospital, 2, Yuh-Der Road, Taichung, 40447, Taiwan. weisyunhu@gmail.com.
- Management Office for Health Data, China Medical University Hospital, Taichung, 40447, Taiwan.
Zitieren
APA
Hu, W. S., & Lin, C. L. (2025). Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03296-0
Vancouver
Hu WS, Lin CL. Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03296-0
BibTeX
@article{Hu2025,
author = {Hu, Wei-Syun and Lin, Cheng-Li},
title = {Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-024-03296-0}
}
EUVIMED